HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children.

Abstract
Ten children with myelodysplastic syndrome underwent an allogeneic bone marrow transplantation (BMT) with an intensified conditioning regimen. The median age of the patients was 8 years (range 2-10), and included 6 males and 4 females. The subtype of the disease was refractory anemia (RA) in 4, RA with excess blasts (RAEB) in 4, RAEB in transformation (RAEB-T) in 1, and juvenile chronic myelogenous leukemia (JCML) in 1. All patients were conditioned with high-dose cytosine arabinoside (12000 mg/m2), cyclophosphamide (120 mg/kg) and either total body irradiation (10-13.2 Gy) or busulfan (16 mg/kg or 560 mg/m2). Cyclosporine A and/or methotrexate were used for the prophylaxis of graft-versus-host disease (GVHD). Engraftment was prompt in all but one patient. Severe acute GVHD (grade 3) (n = 1), interstitial pneumonitis (n = 1) and veno-occlusive disease of the liver (n = 1) occurred. The disease relapsed in one patient with RAEB-T. Seven of the 10 patients were alive and disease free 2-74 months after BMT. The disease-free survival rate at 4 years was 69 +/- 15%. All surviving patients were in the full performance status. The examined children with MDS tolerated this intensified conditioning regimen well.
AuthorsY Nagatoshi, J Okamura, Y Ikuno, M Akamatsu, H Tasaka
JournalInternational journal of hematology (Int J Hematol) Vol. 65 Issue 3 Pg. 269-75 (Apr 1997) ISSN: 0925-5710 [Print] Japan
PMID9114598 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cytarabine
  • Cyclophosphamide
  • Busulfan
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Bone Marrow Transplantation
  • Busulfan (administration & dosage)
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Cytarabine (administration & dosage)
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Myelodysplastic Syndromes (radiotherapy, therapy)
  • Transplantation, Homologous
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: